As noted by Pepe and Longton [34], a useful measure of a model's ability to discriminate for individual breast cancer cases is provided by the percentile of her assigned risk in the distribution of assigned risks for all noncases, which we call her case risk percentile (CRP). The gene discussed is CRP; the disease is breast cancer.